AzTrials
AzTrials

AnalgesiaNCT04250272

Serratus Anterior Plane Block Versus Intercostal Nerve Block for Postoperative Analgesia

A study testing Thoracoscopic lobectomy in people with Analgesia and Postoperative Pain, run by Kyungpook National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A prospective randomized controlled study was undertaken to compare the postoperative analgesic effect between ultrasound-guided serratus anterior plane block and intercostal nerve block after video-assisted thoracoscopic lobectomy. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Analgesia, Postoperative Pain, Lung Cancer
What is being tested?
Thoracoscopic lobectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSouth Korea
Study dates
16 Aug 2019to 29 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • lung cancer
  • American Society of Anesthesiologists (ASA) I-III class
  • Video-assisted thoracoscopic lobectomy

Who cannot join

  • previous history of allergy to local anesthetics
  • psychological disorder
  • chronic analgesics or sedatives use
  • coagulopathy
  • The presence of systemic infection or local infection at injection site
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Kyungpook national university hospital

    Daegu, 700-412

    Jimin Heo, 82-53-420-5430, knuhmrc@knu.ac.kr

    Recruiting

Other trials in South Korea

About this study

Official title: Serratus Anterior Plane Block vs. Intercostal Nerve Block for Postoperative Analgesic Effect After Video-assisted Thoracoscopic Lobectomy: A Randomized Prospective Study

A prospective randomized controlled study was undertaken to compare the postoperative analgesic effect between ultrasound-guided serratus anterior plane block and intercostal nerve block after video-assisted thoracoscopic lobectomy.

Read the detailed description

Post-thoracotomy pain is one of the most notorious postsurgical pains that one can experience. The pain is known to last for an extensive period of time with significantly high intensity.

In field of thoracic surgery, video-assisted thoracoscopic surgery has been played an important role in alleviating the postoperative pain. In field of anesthesiology, various attempts to alleviate post-thoracotomy pain have been tried along advancement of thoracic surgical techniques. It began with postoperative medication of non-steroid anti-inflammatory drugs, opioids and progressed into implementations such as local analgesia, thoracic epidural block, paravertebral block, intercostal nerve block, interpleural block and serratus anterior plane block.

Many analgesic methods have been applied to alleviate postoperative pain in patients who have undergone thoracoscopic surgeries. However, there are no prospective randomized controlled studies between intercostal nerve block and serratus anterior plane block in video-assisted thoracoscopic lobectomy. The main purpose of this study is to compare and analyze the effects between conventional intercostal nerve block and newly introduced serratus anterior plane block in lung cancer patients who have undergone video-assisted thoracoscopic lobectomy.

This prospective study will discover the efficacy and differences between two methods.

Being tested
Thoracoscopic lobectomy
Medical subject headings
Agnosia, Pain, Postoperative, Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thoracoscopic lobectomyProcedure or surgery

    Thoracoscopic lobectomy was performed for lung cancer

Study groups in NCT04250272
Study groupRoleWhat they receive
Serratus Anterior Plane BlockExperimentalSerratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance. 20ml of 0.375% ropivacaine was slowly injected between the fascia of serratus anterior and latissimus dorsi near 5th rib.
Receives: Procedure: Thoracoscopic lobectomy
Intercostal Nerve BlockActive comparatorIntercostal Nerve Block was performed just before closing the surgical incision while looking directly at the affected intercostal space. 10ml of 0.375% ropivacaine was delivered evenly at anterior and posterior intercostal spaces from the port site.
Receives: Procedure: Thoracoscopic lobectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain: numeric rating scale

    Postoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

    Measured: at postanesthesia care unit (PACU)

  2. Postoperative pain: numeric rating scale

    Postoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

    Measured: 3 hours later operation

  3. Postoperative pain: numeric rating scale

    Postoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

    Measured: 6 hours later operation

  4. Postoperative pain: numeric rating scale

    Postoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

    Measured: 12 hours later operation

  5. Postoperative pain: numeric rating scale

    Postoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

    Measured: 24 hours later operation

Secondary outcomes (2)
  1. Number of analgesics consumption

    If the participant has additional analgesic requirement postoperatively, ketorolac 30mg will be injected intravenously when numeric rating scale score is measured as 4-5, and fentanyl 50# is injected when numeric rating scale score is over 6.

    Measured: through study completion, an average of 1 yea

  2. Amount of analgesics consumption

    If the participant has additional analgesic requirement postoperatively, ketorolac 30mg will be injected intravenously when numeric rating scale score is measured as 4-5, and fentanyl 50# is injected when numeric rating scale score is over 6.

    Measured: : through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2020
  2. Study start16 Aug 2019
  3. Primary completion31 Jan 2020 (estimated)
  4. Study completion29 Feb 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04250272
Sponsor's protocol ID
2019-07-008-002
Status last verified
Jan 2020
First submitted
29 Jan 2020
Last updated
31 Jan 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Thoracoscopic lobectomy in people with Analgesia and Postoperative Pain, run by Kyungpook National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jimin Heo (+82-53-420-5430, knuhmrc@knu.ac.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain: numeric rating scale (time frame: at postanesthesia care unit (PACU)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2020; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in